Exchange: NASDAQ·Updated 04:10 PM EDT
CTNM logo

CTNM Contineum Therapeutics Inc. - Ordinary Shares - Class A

$16.70
$0.87
(4.95%)
Today
Closed $16.70
$0.00
(0.00%)
After Hours
EarningsOct 29
Mkt Cap$661M
Vol346,230.00

About CTNM

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
44

Bearish Sentiment

How do you feel about CTNM?

Advertisement|Remove ads.